Pulse Biosciences, Inc. PLSE EBITDA
Discontinued — last reported Q1 '26
EBITDA at other companies
Other financials
Where this comes from
Calculated from Pulse Biosciences, Inc.’s reported figures.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s EBITDA?
- Pulse Biosciences, Inc. (PLSE) reported EBITDA of -$18.9M in Q1 2026.
- How has Pulse Biosciences, Inc.'s EBITDA changed year-over-year?
- Pulse Biosciences, Inc.'s EBITDA decreased by 6.4% year-over-year, from -$17.76M to -$18.9M.
- What is the long-term trend for Pulse Biosciences, Inc.'s EBITDA?
- Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s EBITDA has grown at a 5.2% compound annual growth rate (CAGR), from -$61.9M to -$75.86M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.